Michael M. Lieberman

1.4k total citations
54 papers, 1.1k citations indexed

About

Michael M. Lieberman is a scholar working on Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael M. Lieberman has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 19 papers in Molecular Biology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael M. Lieberman's work include Viral Infections and Vectors (14 papers), Viral Infections and Outbreaks Research (11 papers) and Mosquito-borne diseases and control (10 papers). Michael M. Lieberman is often cited by papers focused on Viral Infections and Vectors (14 papers), Viral Infections and Outbreaks Research (11 papers) and Mosquito-borne diseases and control (10 papers). Michael M. Lieberman collaborates with scholars based in United States, Italy and France. Michael M. Lieberman's co-authors include Alvin Markovitz, David E. Clements, Carolyn Weeks-Levy, Teri Ann S. Wong, Janos Κ. Lanyi, Steven Ogata, Rohit Katial, Axel T. Lehrer, Tom Humphreys and Robert J. Sydiskis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Biochemistry.

In The Last Decade

Michael M. Lieberman

50 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael M. Lieberman United States 19 506 405 280 160 160 54 1.1k
Cesira L. Galeotti Italy 18 335 0.7× 304 0.8× 580 2.1× 236 1.5× 149 0.9× 36 1.3k
Miguel Vargas Mexico 20 402 0.8× 258 0.6× 538 1.9× 158 1.0× 222 1.4× 65 1.5k
Rodger Novak United States 15 419 0.8× 360 0.9× 285 1.0× 452 2.8× 153 1.0× 17 1.2k
Zehava Eichenbaum United States 18 369 0.7× 446 1.1× 472 1.7× 158 1.0× 45 0.3× 37 1.2k
Merribeth J. Morin United States 18 518 1.0× 489 1.2× 309 1.1× 307 1.9× 353 2.2× 33 1.3k
Viviana Castilla Argentina 21 481 1.0× 477 1.2× 471 1.7× 219 1.4× 191 1.2× 42 1.3k
Iris Fedtke Germany 8 259 0.5× 207 0.5× 442 1.6× 149 0.9× 124 0.8× 8 938
Patrick Caspers Switzerland 20 240 0.5× 400 1.0× 706 2.5× 192 1.2× 185 1.2× 36 1.4k

Countries citing papers authored by Michael M. Lieberman

Since Specialization
Citations

This map shows the geographic impact of Michael M. Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Lieberman more than expected).

Fields of papers citing papers by Michael M. Lieberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Lieberman. The network helps show where Michael M. Lieberman may publish in the future.

Co-authorship network of co-authors of Michael M. Lieberman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Lieberman. A scholar is included among the top collaborators of Michael M. Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Lieberman. Michael M. Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Teri Ann S., Michael M. Lieberman, Jake Yalley-Ogunro, et al.. (2023). Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection. Vaccine. 42(3). 598–607. 4 indexed citations
2.
Wong, Teri Ann S., Michael M. Lieberman, Chih-Yun Lai, et al.. (2022). Lyophilized Filovirus Glycoprotein Vaccines: Peroxides in a Vaccine Formulation with Polysorbate 80–Containing Adjuvant are Associated with Reduced Neutralizing Antibody Titers in Both Mice and Non-Human Primates. Journal of Pharmaceutical Sciences. 111(12). 3424–3434. 1 indexed citations
3.
Lehrer, Axel T., Teri Ann S. Wong, Michael M. Lieberman, et al.. (2021). Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses. Frontiers in Immunology. 12. 703986–703986. 31 indexed citations
4.
Wong, Teri Ann S., Michael M. Lieberman, J. P. Harrison, et al.. (2021). Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant. Vaccine. 39(39). 5650–5657. 8 indexed citations
5.
Lai, Chih-Yun, Teri Ann S. Wong, Michael M. Lieberman, et al.. (2021). Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice. Vaccine X. 9. 100126–100126. 14 indexed citations
6.
Lehrer, Axel T., Michael M. Lieberman, Liana Medina, et al.. (2019). Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge. Vaccine. 37(47). 6942–6950. 14 indexed citations
7.
Medina, Liana, Michael M. Lieberman, Teri Ann S. Wong, et al.. (2018). A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates. Frontiers in Immunology. 9. 2464–2464. 33 indexed citations
8.
Lehrer, Axel T., Michael M. Lieberman, Tom Humphreys, et al.. (2017). Recombinant proteins of Zaire ebolavirus induce potent humoral and cellular immune responses and protect against live virus infection in mice. Vaccine. 36(22). 3090–3100. 28 indexed citations
9.
Lieberman, Michael M., Axel T. Lehrer, Tom Humphreys, et al.. (2013). Recombinant Ebolavirus antigens from insect cells are potent immunogens inducing cellular and humoral immunity in rodents and non-human primates and provide protection against virus challenge (P4325). The Journal of Immunology. 190(Supplement_1). 123.26–123.26. 1 indexed citations
10.
Clements, David E., Beth-Ann Coller, Michael M. Lieberman, et al.. (2010). Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys. Vaccine. 28(15). 2705–2715. 160 indexed citations
11.
Lieberman, Michael M., David E. Clements, Steven Ogata, et al.. (2006). Preparation and immunogenic properties of a recombinant West Nile subunit vaccine. Vaccine. 25(3). 414–423. 59 indexed citations
12.
Watts, Douglas M., Robert B. Tesh, Marina Siirin, et al.. (2006). Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis. Vaccine. 25(15). 2913–2918. 35 indexed citations
13.
14.
Lieberman, Michael M., Gregory M. L. Patterson, & Richard E. Moore. (2001). In vitro bioassays for anticancer drug screening: effects of cell concentration and other assay parameters on growth inhibitory activity. Cancer Letters. 173(1). 21–29. 32 indexed citations
15.
16.
White, Christopher B., et al.. (1988). Evaluation of the throat culture as a follow-up for an initially negative enzyme immunosorbent assay rapid streptococcal antigen detection test. The Pediatric Infectious Disease Journal. 7(11). 765–768. 7 indexed citations
17.
Lieberman, Michael M., et al.. (1988). Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. I. In vivo protection studies in compromised animal models. Journal of Surgical Research. 44(3). 242–250. 2 indexed citations
18.
Lieberman, Michael M., et al.. (1983). Active and passive immunity against Pseudomonas aeruginosa with a ribosomal vaccine and antiserum in C3H/HeJ mice.. The Journal of Immunology. 131(1). 1–3. 38 indexed citations
19.
Lieberman, Michael M., et al.. (1980). Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains. Infection and Immunity. 29(2). 489–493. 9 indexed citations
20.
Lieberman, Michael M. & Janos Κ. Lanyi. (1972). Threonine deaminase from extremely halophilic bacteria. Cooperative substrate kinetics and salt dependence. Biochemistry. 11(2). 211–216. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cesira L. Galeotti Breakdown of academic impact, for papers by Miguel Vargas Breakdown of academic impact, for papers by Rodger Novak Breakdown of academic impact, for papers by Zehava Eichenbaum Breakdown of academic impact, for papers by Merribeth J. Morin Breakdown of academic impact, for papers by Viviana Castilla Breakdown of academic impact, for papers by Iris Fedtke Breakdown of academic impact, for papers by Patrick Caspers
Rankless by CCL
2026